Record Information |
---|
Version | 5.0 |
---|
Status | Expected but not Quantified |
---|
Creation Date | 2012-09-06 15:16:52 UTC |
---|
Update Date | 2022-03-07 02:52:04 UTC |
---|
HMDB ID | HMDB0015658 |
---|
Secondary Accession Numbers | |
---|
Metabolite Identification |
---|
Common Name | Norelgestromin |
---|
Description | Norelgestromin is only found in individuals that have used or taken this drug. It is a drug used in contraception. Norelgestromin is the active progestin responsible for the progestational activity that occurs in women after application of ORTHO EVRA patch. Norelgestromin inhibits estrone sulfatase, which converts sulfated steroid precursors to estrogen during pregnancy. Norgelgestromin/ethinylestradiol suppresses follicular development, induces changes to the endometrium, which decreases chances of implantation and thickens the cervical mucus, impeding sperm swimming into the uterus. It also has similar agonisting binding affinities as its parent compound, Norgestimate, for progesterone and estrogen receptors. |
---|
Structure | CCC12CCC3C(CCC4=CC(CCC34)=NO)C1CCC2(O)C#C InChI=1S/C21H29NO2/c1-3-20-11-9-17-16-8-6-15(22-24)13-14(16)5-7-18(17)19(20)10-12-21(20,23)4-2/h2,13,16-19,23-24H,3,5-12H2,1H3 |
---|
Synonyms | Value | Source |
---|
17-Deacetylnorgestimate | HMDB | LNGO | HMDB | Levonorgestrel oxime | HMDB | Levonorgestrel oxime, (3E,17alpha)-isomer | HMDB | Levonorgestrel oxime, (3Z,17alpha)-isomer | HMDB | Progestin norelgestromin | HMDB |
|
---|
Chemical Formula | C21H29NO2 |
---|
Average Molecular Weight | 327.4605 |
---|
Monoisotopic Molecular Weight | 327.219829177 |
---|
IUPAC Name | 15-ethyl-14-ethynyl-5-(hydroxyimino)tetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadec-6-en-14-ol |
---|
Traditional Name | orthra evra |
---|
CAS Registry Number | 53016-31-2 |
---|
SMILES | CCC12CCC3C(CCC4=CC(CCC34)=NO)C1CCC2(O)C#C |
---|
InChI Identifier | InChI=1S/C21H29NO2/c1-3-20-11-9-17-16-8-6-15(22-24)13-14(16)5-7-18(17)19(20)10-12-21(20,23)4-2/h2,13,16-19,23-24H,3,5-12H2,1H3 |
---|
InChI Key | ISHXLNHNDMZNMC-UHFFFAOYSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as estrane steroids. These are steroids with a structure based on the estrane skeleton. |
---|
Kingdom | Organic compounds |
---|
Super Class | Lipids and lipid-like molecules |
---|
Class | Steroids and steroid derivatives |
---|
Sub Class | Estrane steroids |
---|
Direct Parent | Estrane steroids |
---|
Alternative Parents | |
---|
Substituents | - Estrane-skeleton
- Hydroxysteroid
- 17-hydroxysteroid
- Delta-4-steroid
- Ynone
- Cyclic alcohol
- Ketoxime
- Tertiary alcohol
- Oxime
- Acetylide
- Organooxygen compound
- Organonitrogen compound
- Organopnictogen compound
- Organic oxygen compound
- Organic nitrogen compound
- Alcohol
- Hydrocarbon derivative
- Aliphatic homopolycyclic compound
|
---|
Molecular Framework | Aliphatic homopolycyclic compounds |
---|
External Descriptors | Not Available |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | |
---|
Process | Not Available |
---|
Role | Not Available |
---|
Physical Properties |
---|
State | Solid |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | Not Available | Not Available |
|
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatizedDerivatized |
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted GC-MS | Predicted GC-MS Spectrum - Norelgestromin GC-MS (Non-derivatized) - 70eV, Positive | splash10-0002-1591000000-d15c9fb4d4be46393c12 | 2017-09-01 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Norelgestromin GC-MS (1 TMS) - 70eV, Positive | splash10-00e9-1459000000-c21d7ad1916eda54f442 | 2017-10-06 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Norelgestromin GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Norelgestromin 10V, Positive-QTOF | splash10-004i-0019000000-aa08354d41171a2e94d2 | 2017-09-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Norelgestromin 20V, Positive-QTOF | splash10-01r2-0195000000-1f698646faea40b0ff22 | 2017-09-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Norelgestromin 40V, Positive-QTOF | splash10-07bf-5691000000-8713c690ec4c0dedbb0b | 2017-09-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Norelgestromin 10V, Negative-QTOF | splash10-004i-0009000000-856211f15c7d2df57e00 | 2017-09-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Norelgestromin 20V, Negative-QTOF | splash10-004i-0029000000-0fbf66f0573d98dd247b | 2017-09-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Norelgestromin 40V, Negative-QTOF | splash10-0a59-3093000000-88fe0954b453600797c9 | 2017-09-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Norelgestromin 10V, Positive-QTOF | splash10-03e9-0049000000-bb736099f135ec98040d | 2021-10-11 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Norelgestromin 20V, Positive-QTOF | splash10-01q9-0394000000-d79abdaa7f1d7be949e4 | 2021-10-11 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Norelgestromin 40V, Positive-QTOF | splash10-01rw-0890000000-2055bc9542a620a0aeb9 | 2021-10-11 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Norelgestromin 10V, Negative-QTOF | splash10-004i-0009000000-ad4847b3b72e4c91ee0a | 2021-10-11 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Norelgestromin 20V, Negative-QTOF | splash10-004j-0049000000-6a932430636eca9316f6 | 2021-10-11 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Norelgestromin 40V, Negative-QTOF | splash10-00kb-0191000000-181ebb18ff8c35e8eaa2 | 2021-10-11 | Wishart Lab | View Spectrum |
|
---|
General References | - Henzl MR: Norgestimate. From the laboratory to three clinical indications. J Reprod Med. 2001 Jul;46(7):647-61. [PubMed:11499185 ]
- Abrams LS, Skee DM, Wong FA, Anderson NJ, Leese PT: Pharmacokinetics of norelgestromin and ethinyl estradiol from two consecutive contraceptive patches. J Clin Pharmacol. 2001 Nov;41(11):1232-7. [PubMed:11697756 ]
- Goa KL, Warner GT, Easthope SE: Transdermal ethinylestradiol/norelgestromin: a review of its use in hormonal contraception. Treat Endocrinol. 2003;2(3):191-206. [PubMed:15966567 ]
- Simons K, Toomre D: Lipid rafts and signal transduction. Nat Rev Mol Cell Biol. 2000 Oct;1(1):31-9. [PubMed:11413487 ]
- Watson AD: Thematic review series: systems biology approaches to metabolic and cardiovascular disorders. Lipidomics: a global approach to lipid analysis in biological systems. J Lipid Res. 2006 Oct;47(10):2101-11. Epub 2006 Aug 10. [PubMed:16902246 ]
- Sethi JK, Vidal-Puig AJ: Thematic review series: adipocyte biology. Adipose tissue function and plasticity orchestrate nutritional adaptation. J Lipid Res. 2007 Jun;48(6):1253-62. Epub 2007 Mar 20. [PubMed:17374880 ]
- Lingwood D, Simons K: Lipid rafts as a membrane-organizing principle. Science. 2010 Jan 1;327(5961):46-50. doi: 10.1126/science.1174621. [PubMed:20044567 ]
- Gunstone, Frank D., John L. Harwood, and Albert J. Dijkstra (2007). The lipid handbook with CD-ROM. CRC Press.
|
---|